ORIC Pharmaceuticals, Inc. (ORIC)
NASDAQ: ORIC · Real-Time Price · USD
5.31
-0.10 (-1.85%)
May 13, 2025, 4:00 PM - Market closed

ORIC Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Market Capitalization
3775695022655791,240
Upgrade
Market Cap Growth
-57.22%13.47%89.55%-54.26%-53.31%-
Upgrade
Enterprise Value
182307285843021,053
Upgrade
Last Close Price
5.318.079.205.8914.7033.85
Upgrade
PB Ratio
1.722.342.241.192.124.28
Upgrade
P/TBV Ratio
1.722.342.241.192.124.28
Upgrade
Debt / Equity Ratio
0.040.040.050.050.05-
Upgrade
Quick Ratio
11.5610.3010.1813.4115.6432.62
Upgrade
Current Ratio
12.0010.5610.3913.6815.8832.96
Upgrade
Return on Equity (ROE)
-48.45%-54.73%-45.11%-35.98%-27.98%-39.02%
Upgrade
Return on Assets (ROA)
-30.87%-33.95%-27.74%-19.87%-16.50%-15.69%
Upgrade
Return on Capital (ROIC)
-32.34%-36.69%-29.54%-20.86%-17.14%-16.33%
Upgrade
Earnings Yield
-35.20%-22.45%-20.06%-33.66%-13.60%-5.94%
Upgrade
FCF Yield
-30.83%-19.99%-17.24%-29.17%-10.45%-3.70%
Upgrade
Buyback Yield / Dilution
-23.91%-35.52%-29.74%-4.48%-72.97%-1055.26%
Upgrade
Updated May 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q